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INTRODUCTON
In animals, the initial development of the central nervous
system (CNS) occurs during embryogenesis when neurons
send out their processes, axons, to establish a stereotypical
arrangement of axon bundles. Glial cells constitute the second
major component of the nervous systems of all multicellular
organisms. The function of the nervous system as a whole
depends on the correct specification and function of both
neurons and glia. Glia are essential for controlling proliferation
rates of vicinal neuroblasts (Ebens et al., 1993) and for the
correct establishment and survival of the axon scaffold (Booth
et al., 2000; Hidalgo and Booth, 2000; Hidalgo and Brand,
1997; Hidalgo et al., 1995; Xiong and Montell, 1995).
Furthermore, glia ensheath axon bundles, providing electro-
insulation and spatial separation from neighbouring
haemocytes, thereby creating the blood-brain barrier
(Granderath et al., 1999b).
The two characterized classes of glial cells studied so far
in the embryonic CNS of Drosophila are the midline glia
(proposed to correspond to the floor plate of vertebrates) and
longitudinal glia (reminiscent of vertebrate oligodendrocytes).
These cells are distinguished on the basis of their different
positions and patterns of gene expression. Midline glia, which
originate from the mesectoderm, depend on expression of the
single-minded (sim) gene and activation of the EGF signalling
pathway for their development (Hummel et al., 1999; Klambt
et al., 1991; Stemerdink and Jacobs, 1997). The ultimate
phenotype of embryos mutant for genes essential for midline
development is the absence of axon commissures and collapse
of the longitudinal axon connectives.
Longitudinal glia are a heterogenous population of cells, the
specification of which depends on the activity of the gene glial
cells missing/glial cell deficient (gcm/glide). gcm encodes a
transcription factor which binds to a conserved eight nucleotide
DNA-binding motif called the GCM motif (Akiyama et al.,
1996; Bernardoni et al., 1998; Hosoya et al., 1995; Jones et al.,
1995; Schreiber et al., 1997; Vincent et al., 1996). GCM is a
master regulator of glial development, acting as a switch
between neural and glial cell fates. GCM performs its function
through activation of the gene tramtrack (ttk), which encodes a
zinc-finger protein that acts as a repressor of neural cell fate
(Badenhorst, 2001; Giesen et al., 1997; Van De Bor et al., 2000).
Concomitantly with repression of the neural cell fate, GCM
triggers expression of proteins that mediate glial cell
differentiation. These include a GCM homolog GLIDE2, the
ETS domain protein Pointed (PNT), the homeodomain protein
Reversed polarity (REPO) and Locomotion defects (LOCO), a
1505Development 130, 1505-1513 
© 2003 The Company of Biologists Ltd
doi:10.1242/dev.00377
The Drosophila dead ringer (dri, also known as retained,
retn) gene encodes a nuclear protein with a conserved DNA-
binding domain termed the ARID (AT-rich interaction
domain). We show here that dri is expressed in a subset
of longitudinal glia in the Drosophila embryonic central
nervous system and that dri forms part of the
transcriptional regulatory cascade required for normal
development of these cells. Analysis of mutant embryos
revealed a role for dri in formation of the normal embryonic
CNS. Longitudinal glia arise normally in dri mutant
embryos, but they fail to migrate to their final destinations.
Disruption of the spatial organization of the dri-expressing
longitudinal glia accounts for the mild defects in axon
fasciculation observed in the mutant embryos. Consistent
with the late phenotypes observed, expression of the glial
cells missing (gcm) and reversed polarity (repo) genes was
found to be normal in dri mutant embryos. However, from
stage 15 of embryogenesis, expression of locomotion defects
(loco) and prospero (pros) was found to be missing in a
subset of LG. This suggests that loco and pros are targets
of DRI transcriptional activation in some LG. We conclude
that dri is an important regulator of the late development
of longitudinal glia. 
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regulator of G-protein signalling (Campbell et al., 1994;
Granderath et al., 1999b; Halter et al., 1995; Kammerer and
Giangrande, 2001; Klaes et al., 1994; Klambt, 1993; Klambt and
Goodman, 1991; Xiong et al., 1994). Activation of the
expression of another glial-specific homeodomain protein,
Prospero (PROS), in a subset of LG (six out of ten LG
per hemisegment), depends on the activity of the
DROP/MSH/Lottchen protein (DR – FlyBase) (Buescher and
Chia, 1997; Doe et al., 1991). In gcm and glide2 mutants, all
glial cells acquire a default neural cell fate (Akiyama et al., 1996;
Hosoya et al., 1995; Jones et al., 1995; Kammerer and
Giangrande, 2001). Surprisingly, when PNT, REPO, LOCO or
PROS functions are abrogated, longitudinal glia are still formed,
albeit in a spatially disorganized fashion, indicating a failure to
undergo terminal differentiation (Buescher and Chia, 1997).
Longitudinal glial cells are involved in the formation of the
longitudinal axon fascicles by aiding navigation of the pioneer
axon growth cones and by directing the fasciculation and
defasciculation of axons (Hidalgo and Booth, 2000). Moreover,
longitudinal glia are essential for follower axon survival during
Drosophila embryogenesis (Booth et al., 2000).
The loss of correctly specified glia in either gcm, glide2 or
Drop/MSH/ltt mutant embryos accounts for the severe defects
in the longitudinal connectives observed in these embryos
(Akiyama et al., 1996; Buescher and Chia, 1997; Hosoya et al.,
1995; Jones et al., 1995; Kammerer and Giangrande, 2001). By
contrast, mutations in any of the pnt, repo, loco and pros genes
result in fasciculation defects that are much weaker than those
observed in the gcm mutant embryos (Buescher and Chia,
1997; Granderath and Klambt, 1999a). Embryos lacking any
of these gene products develop with minor defasciculation of
the longitudinal connectives. 
Despite some progress in understanding the specification of
the longitudinal glia, many genes involved in this process
remain unidentified and the role of some of the known genes
is not fully elucidated (Egger et al., 2002). One candidate for
a role in embryonic CNS development is the Drosophila dead
ringer/retained gene (dri/retn, here referred to as dri) (retn –
FlyBase), because of its expression in the embryonic CNS
(Gregory et al., 1996). dri encodes a nuclear protein with a
conserved DNA binding domain termed the ARID [AT-rich
interaction domain (Gregory et al., 1996) (reviewed by
Kortschak et al., 2000)]. Analysis of the early stages of
Drosophila embryogenesis showed that DRI is involved in
aspects of dorsal/ventral and anterior/posterior axis formation
acting either as a repressor or an activator depending on a
particular developmental context (Valentine et al., 1998; Hader
et al., 2000; Shandala et al., 1999). Later in embryogenesis, dri
is required for myogenesis and hindgut development (Shandala
et al., 1999).
We describe a role for dri in the formation of a functional
CNS during Drosophila embryogenesis. We show that dri is
expressed in a subset of glial cells as part of the cascade of
transcriptional regulation that occurs during glial cell
differentiation. dri mutant embryos are shown to exhibit mild
defasciculation defects, similar to those caused by LG
differentiation defects in pnt, repo, loco and pros mutant
embryos. Finally, the dri mutant longitudinal glia are shown to
be defective in their ability to migrate along the longitudinal
axonal tracts to their proper positions, providing a cellular basis
for the observed axon phenotype.
MATERIALS AND METHODS
Fly stocks
Two protein null alleles, dri1 and dri2, described previously (Shandala
et al., 1999), were used during the course of this work. Enhancer trap
and reporter lines used were: AA142, which labels midline glia; X55,
which labels midline neurons (Klambt et al., 1991); gcm enhancer trap
lines rA87 (Jones et al., 1995; Vincent et al., 1996) and gcmP (Hosoya
et al., 1995); rc56, a loco enhancer trap line (Klaes et al., 1994); and
P2333, a Star enhancer trap (Spradling et al., 1999). For targeted
expression of dri in the embryonic CNS, the yeast Gal4-UAS system
was used (Brand and Perrimon, 1993). A previously reported UAS-
dri construct (Shandala et al., 1999) was placed under the control of
several Gal4-expressing constructs: KrGal4 (which expresses GAL4
in T2-A4), simGal4 (which expresses GAL4 in the embryonic
midline, provided by C. Klambt, University of Muenster, Germany)
and MZ1580 (a PGAL4 insertion in the actin locus, which directs
GAL4 expression in the longitudinal glia and its progeny as well as
in MP2 neurons and macrophages, provided by G. Technau, Institute
of Genetics, University of Mainz, Germany). The gcmP1 amorphic
allele was provided by B. W. Jones (Skirball Institute, NYU School
of Medicine, NY). Unless specified, fly stocks were obtained from
the Bloomington Drosophila Stock Center (Indiana University,
Bloomington, IN).
Antibodies and staining methods
A rat polyclonal antibody raised against a bacterially expressed
pGEX-DRI fusion protein (Gregory et al., 1996) was used to detect
the distribution of DRI in embryos. Polyclonal anti- b -gal was
obtained from Rockland Immunochemicals (Gilbertsville, PA), anti-
REPO was provided by A. Travers (Laboratory of Molecular Biology,
Medical Research Council, Cambridge, UK), anti-Eve was provided
by J. Reinitz (The University at Stony Brook, NY), the monoclonal
antibodies 1D4 anti-FasII and 1B7 were provided by C. Goodman
(University of California, Berkeley, CA), and anti-GFP was provided
by P. Silver (Dana Faber Cancer Inst, Boston, MA) (Seedorf et al.,
1999). The monoclonal antibodies 9F8A9 anti-ELAV, 2B10 anti-CUT,
MR1A anti-PROS, 22C10, BP 102 and 4D9 anti-EN were all obtained
from the Developmental Studies Hybridoma Bank (The University
of Iowa, Iowa City, USA). For immunohistochemistry, anti-IgG
secondary antibodies conjugated with AP, HRP, Cy5 and Lissamine-
Rhodamine (Jackson ImmunoResearch Laboratories, PA), and
Alexa488 (Molecular Probes, OR) were used. Biotinylated anti-IgG
secondary antibodies and AP-, Lissamine-Rhodamine-conjugated
streptavidin (Jackson ImmunoResearch Laboratories, PA) were used
where signal enhancement was required. Immunohistochemical
staining was carried out according to the method of Foe (Foe, 1989).
Embryos were mounted in phosphate-buffered saline (PBS)
containing 80% glycerol and viewed with epifluorescence using a
Zeiss Axiophot or by confocal microscopy using a BioRad MRC1000
scanhead equipped with a krypton/argon laser confocal microscope.
RESULTS
dead ringer is expressed in longitudinal glial cells
Gregory et al. have reported expression of dri in the CNS
of Drosophila embryos (Gregory et al., 1996). To better
characterize the pattern of expression, we co-stained embryos
with the axon marker, monoclonal antibody 22C10 and anti-
DRI antibodies. The staining revealed that some of the dri-
expressing cells lie close to the midline (Fig. 1A, arrow). To
further examine the nature of these cells, we used enhancer trap
lines with previously described patterns of b -galactosidase
expression in mesectoderm-derived cells: X55 (P element
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insertion at 56E, expresses in the VUM neurones, the MNB
and its support cells, and the posterior pair of the midline glia,
Fig. 1B), P 2333 [a Star enhancer trap insertion (Spradling et
al., 1999) (Fig. 1C)] and AA142 (a P element insertion at 66D
that expresses b -galactosidase in the midline glia, MGA, MGM
and MGP; Fig. 1D). No correspondence was observed between
these markers and dri-expressing cells. However, using the
midline-derived cell markers as positional landmarks, we could
infer that the dri-positive cells correspond to dorsally located
glial cells. 
To confirm this, we employed specific molecular markers:
the enhancer trap lines rA87 (gcm, Fig. 2A,B), pntrm254 (Fig.
2C) and rC56 (loco, Fig. 2D), and the antibodies anti-REPO
(Fig. 2E), anti-PROS (Fig. 2F) and anti-CUT (Fig. 2G). Co-
expression of DRI with these glial markers confirmed that, with
the exception of one cell per hemisegment at the very lateral
edge of the ventral nerve cord (VNC, notched arrowheads in
Fig. 1A-D), the dri-positive cells are longitudinal glia. 
Based on their position within the VNC, the dorsal glia can
be subdivided into the longitudinal glial (LG), the A and B
subperineural glia (A/B SPG), which are positioned at the
medial edge of the longitudinal glia, and the medialmost cell
body glia (MM-CBG), which are located in the very medial
position within the cortex (Halter et al., 1995; Ito et al., 1995;
Jacobs et al., 1989; Klambt and Goodman, 1991; Udolph et al.,
1993) (summarized in Fig. 2H). All LG, A/B SPG and MM-
CBG express gcm, repo and cut (Fig. 2A,B,E,G). dri appears
to be expressed in eight out of ten of the LG (Fig. 2, short
arrows). It is known that the LG comprise eight cells that are
the progeny of lateral glioblasts, plus approx. two cells per
hemineuromere that are of unknown origin. The latter
intermingle with other longitudinal glial cells and cannot be
distinguished by their position or any molecular marker from
stage 13 of embryogenesis (Halter et al., 1995; Ito et al., 1995;
Fig. 1. dri is not expressed in midline-derived cells of the Drosophila
embryonic CNS. Confocal micrographs of stage 15 whole-mount
embryos carrying specific enhancer trap lines directing b -
galactosidase expression in midline cells of the CNS. Embryos were
immunochemically stained with polyclonal rabbit anti- b -gal
(Alexa488-conjugated secondary antibody, green) and rat anti-DRI
(Lissamine-Rhodamine-conjugated secondary antibody, red).
Anterior is towards the left. Some dri-positive cells are located in the
vicinity of the embryonic midline: (A) Posterior to the posterior
commissures (arrow) as revealed by the mAb 22C10 axonal marker;
(B) posterior to X55-positive cells (the VUM neurones, the MNB
and its support cells and the posterior pair of the midline glia)
(arrow); (C) posterior to Star-positive (P 2333) midline glia (long
arrow); and (D) half way between neighbouring segmental clusters of
AA142-positive midline glia (MGA, MGM and MGP) (long arrow).
There is one dri-positive cell per hemineurome located at the very
edge of the VNC (A-D, notched arrowhead), posterior to the
intersegmental nerve root as revealed by the mAb 22C10 (A). Other
dri-positive CNS cells are labelled with short arrows in C-D. 
Fig. 2. dri is expressed in longitudinal glial cells of the Drosophila
embryonic CNS. Confocal micrographs of stage 15 whole-mount
embryos. Embryos are immunochemically stained with polyclonal
rabbit anti-b -galactosidase (Alexa488-conjugated secondary
antibody, green) and rat anti-DRI (Lissamine-Rhodamine-conjugated
secondary antibody, red). Anterior is towards the left. (A,B) Focal
planes showing that dri is expressed in the medialmost cell body glia
(MM CBG, arrow in A), the subperineural glia (SPG, double
arrowheads in B) and longitudinal glial (LG, short arrow in B) that
express b -galactosidase in the rA87 enhancer trap line. (C) dri is
expressed in the A and B SPG (double arrowhead) and LG (short
arrow) that express b -galactosidase in the pntrm254 enhancer trap line.
(D) dri is expressed in the A and B SPG (double arrowheads) and LG
(short arrow) that express b -galactosidase in the rC56 enhancer trap
line. (E) dri is expressed in the A and B SPG (double arrowhead) and
LG (short arrow) that express repo. (F) dri is expressed in all six
prospero-expressing LG (short arrows, only five of these cells are in
focus). (G) ct and dri are co-expressed in the LG (short arrow).
(H) CNS stained for DRI alone showing the assignments of cells
derived from the data shown in (A-F): LG (short arrow), A and B
SPG (double arrowheads), MM CBG (long arrow) and N (neurone,
notched arrowhead).
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Jacobs et al., 1989; Klambt and Goodman, 1991; Udolph et al.,
1993). Our data would be explained if dri is expressed in the
eight progeny of the lateral glioblasts, but not in the two cells
of unknown origin, but this is yet to be confirmed. 
The A/B SPG and MM CBG express dri (Fig. 2). pnt and
loco are expressed in the A/B SPG, but not the MM-CBG (Fig.
2C, data for loco are not shown). pros colocalizes with dri in
only five LG per hemineuromere, but is absent from the A/B
SPG and the MM-CBG (Fig. 2F). 
In addition to the dri-positive glia, each hemineuromere has
one lateral cell located posterior to the intersegmental nerve
root (as revealed by the mAb 22C10 axon marker; Fig. 1A,
arrowhead). The origin of these cells is unknown, but they do
not express any glial specific marker (Fig. 2A-F) and they
project axons along the longitudinal tracts (K.-L. Harris and
P. Whitington, personal communication), confirming their
identity as interneurons. The nature of these cells and the role
of dri in their development is not considered further in this
report.
dri is not involved in the neural/glial cell fate switch
Expression of dri in the embryonic CNS is first clearly detected
at stage 11 in a single cell per hemineuromere, probably
corresponding to the lateral glioblast (data not shown). DRI
continues to be expressed while the daughter glial cells divide
and migrate anteromedially (Fig. 3A). 
The early expression of dri in a subset of longitudinal glia
suggested that dri might be required for the initial neurone/glia
fate decision. To test this, we first examined the distribution of
repo-positive cells in dri mutant embryos from stage 11 up
until stage14. The correct position and number of these repo-
positive cells (Fig. 3B) suggested that initiation of gliogenesis
is not affected in the absence of DRI.
We then tested whether ectopic expression of dri could
induce glial fates in non-glial cells, as has been shown for gcm
and pnt (Bernardoni et al., 1998; Klaes et al., 1994). However,
sim-GAL4-induced expression of dri in midline cells was
found not to increase the number of glial cells, as measured
by the expression of repo (Fig. 3C, compare with 3D).
Furthermore, when dri is driven by the MZ1580-GAL4
enhancer trap line that is specific for longitudinal glia and their
progeny, as well as for MP2 neurones and macrophages, there
were no ectopic pros-positive cells (data not shown). Ectopic
expression of dri is therefore not sufficient to induce a glial
cell fate. 
Glial differentiation requires repression of the neuronal fate
by the 69 kDa Tramtrack isoform (TTK69) (Badenhorst, 2001;
Giesen et al., 1997). Overexpression of TTK69 in neuronal
cells blocks neural differentiation. To test whether dri is
capable of repressing the neural fate, we drove expression of
UAS-dri in the T2-A4 segments using Kr-GAL4. In contrast
to the effect of expressing TTK69, ectopic expression of DRI
did not prevent normal neural differentiation in the CNS or
PNS, as assayed by expression of the neuronal marker, ELAV
(Fig. 3E, between arrowheads). The normal differentiation of
neural cells also suggests that glial cell fate is not induced by
DRI in the Kr-specific domain. Loss of TTK69 results in
general derepression of the 22C10 neural specific antigen in
somatic muscles (Giesen et al., 1997). In dri mutants, however,
this antigen was observed in its normal pattern, i.e. in a single
somatic muscle fibre (Fig. 3F). These results show that dri does
not induce the glial fate, nor does it repress the neural cell fate. 
Longitudinal axon tracts are defasciculated in dri
mutant embryos
As the next step in exploring possible roles for dri in the
LG, we investigated the organization of the longitudinal
connectives. Axon projections along the VNC and the
subsequent formation of longitudinal connectives depend on
the proper function of longitudinal glia (Hidalgo and Booth,
2000; Hidalgo and Brand, 1997). During formation of the first
longitudinal tract, LG navigate ipsilateral pioneer axons. Upon
establishing contacts with axons, glia continue migrating along
the longitudinal bundles, occupying choice points of axon
fasciculation or defasciculation. The final fasciculation pattern
can be visualized as three longitudinal Fasciclin 2 (Fas2)-
positive (mAb1D4-staining) bundles on either
side of the midline of stage 15-16 embryos
(Grenningloh et al., 1991) (Fig. 4C). 
In dri mutant embryos, the first processes
projected by neurons were found to be normal (data
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Fig. 3. DRI is not involved in initiation of the glial cell
fate or repression of the neural cell fate decision in
lateral glioblasts. (A) dri expression in longitudinal glia
of a stage 12 embryo (arrow). (B) Whole-mount stage
12 dri1/dri2 embryo, derived from a maternal dri1
homozygous germline clone, stained with anti-REPO
antibody. Loss of maternal and zygotic DRI does not
interfere with the early behaviour of the LG. (C) Wild-
type stage 15 embryo stained with anti-REPO antibody.
(D) Ectopic expression of dri in the mesectoderm using
sim-GAL4 does not induce longitudinal glial cell fate
specification, as detected by anti-REPO staining
(compare with C). (E) Ectopic expression of dri in
parasegments T2-A4 using Kr-GAL4 (between
arrowheads) does not inhibit neural differentiation, as
detected by anti-ELAV antibody. (F) 22C10 antigen is
correctly localized in a single somatic muscle fibre in
dri1/dri2 homozygotes (arrowheads). 
1509dead ringer and embryonic CNS development
not shown). This is expected, given that dri is not required for
the specification of the longitudinal glia. Furthermore, at stages
11-14, no gross abnormalities were observed in the initial
formation of the longitudinal connectives (Fig. 4B, compare
with 4A). However, in stage 15-16 embryos, moderate but
consistent fasciculation defects were observed in dri mutant
embryos. Some axons were not bundled correctly within the
fascicles, which appeared thinner and were occasionally found
at the dorsal surface of the VNC (Fig. 4C-E). Axons were
observed to occasionally join the wrong bundle or cross
inappropriately between bundles, although they never crossed
the midline. Moreover, the spacing between the first and second,
and between the second and third parallel bundles was slightly
increased. The severity of this phenotype was much less than
that observed in gcm mutant embryos (Hosoya et al., 1995;
Jones et al., 1995; Vincent et al., 1996) (see Fig. 4G), but was
similar to the level of disruption observed in pnt mutant
embryos (Klaes et al., 1994; Scholz et al., 1993) (Fig. 4F). 
This phenotype could arise as a consequence of neural or
glial defects. With the aim of showing the glial-specificity of
the dri phenotype, we attempted to rescue the axon defects by
directing expression of UAS-dri in longitudinal glia using
the MZ1580-GAL4 transgene (Hidalgo et al., 1995).
Unfortunately, overexpression of dri interfered with normal
glial development, causing misplacement of pros-positive cells
and severe defasciculation of axons (data not shown). However,
the possibility that the phenotype arose as a result of an indirect
effect of DRI on neuronal development was ruled out by
staining dri mutant embryos with anti-EVE, anti-EN,
mAbBP102 and mAb22C10, and finding no defects in neural
differentiation (data not shown).
Misplacement of longitudinal glial cells in dri mutant
embryos
The fasciculation defects showed that the dri mutant
longitudinal glia were defective in their axon guidance role. To
understand the nature of this defect further, we examined the
behaviour of these cells in dri mutant embryos. In wild-type
stage16 embryos, the longitudinal glia form two flat sheets of
cells either side of the midline underlying the dorsal surface of
the axon tracts (Halter et al., 1995; Jacobs et al., 1989; Schmidt
et al., 1997) (Fig. 5A,C,E). In dri mutant embryos, these cells
were found to occupy a normal position relative to the midline,
indicating that the LG had undergone their appropriate initial
anterior-medial migration from their place of birth at the very
lateral edge of the VNC (Fig. 5B,D). However, a pronounced
defect in spatial organisation of the glia was observed. The
mutant cells were ventrally shifted and not localized to the
characteristic flat cell sheet on the dorsal side of the
longitudinal connectives with only one or two out of ten glial
cells per hemineuromere being in any one focal plane (Fig. 5F,
compare with 5E). 
Significantly, there is a high degree of similarity in the
spatial disorganisation of the two rows of longitudinal glia in
dri (Fig. 5F), loco and pnt mutant embryos (Granderath et
al., 1999b). The pnt phenotype is associated with partial
misregulation of loco expression, suggesting possible
regulatory relationships between pnt, loco and dri, a possibility
that is explored further below.
Longitudinal glia exhibit aberrant cell shapes in dri
mutants
To characterize the cellular dri phenotype further, we used the
gcmP1 enhancer trap, which expresses b -galactosidase, and
monoclonal antibody 1B7, which recognizes both the neuronal
and non-neuronal form of the Neuroglian protein. Comparison
between the wild-type (Fig. 6A-C) and dri-mutant (Fig. 6D-F)
phenotypes of stage 14 CNS preparations revealed that some
glia lose expression of the cell adhesion protein, Neuroglian
(Fig. 6E,F, arrows). Significantly, Neuroglian-deficient glial
cells show somewhat round shapes compared with the more
elongated wild-type glia (Fig. 6, compare B with E).
Misregulation of the cell adhesion protein Neuroglian might
Fig. 4. Loss of DRI results in axon defasciculation in the Drosophila
embryonic CNS. Dorsal view of dissected ventral nerve cord
preparations. Anterior is towards the left. (A) The first axon bundle
in control dri heterozygotes is revealed by anti-GFP staining of ftz-
GAL4-driven UAS-tauGFP. (B) ftz-GAL4-driven UAS-tauGFP
staining of a dri homozygous mutant embryo shows that the first
axon bundle is correctly established. (C) Immunochemical staining
with mAB 1D4, which recognizes the Fasciclin 2 protein, reveals the
three axon bundles either side of the midline in a wild-type stage 16
embryo. (D) In dri1/dri2 mutant embryos, the first axon tract
occupies the correct position relative to the midline, while the
spacing between other tracts is slightly increased. Moreover, a
moderate axon defasciculation is evident. In addition, axons
occasionally cross between fascicles (arrow). (E) Another example of
a dri1/dri2 mutant embryos, showing defasciculation of the three
axon bundles. (F) pntrm254 mutants exhibit a mild defasciculation of
axons, similar to those observed in dri mutant embryos. (G) Strong
pathfinding defects are observed in gcmP1 mutant embryos.
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impede cell-cell contacts leading to cell shape changes and
failure of glia to migrate normally along the axon tracts. 
dri activity and the glial cell transcriptional
regulatory cascade
As noted above, the similarity between the dri phenotypes
and those of repo, loco and pnt suggested that gene regulatory
relationships might exist between these genes. A considerable
amount of information already exists about the nature of the
transcriptional cascade required to establish longitudinal glial
cells. The glial fate is induced by expression of gcm, while
later expression of transcription factors encoded by repo and
pnt direct glial differentiation (Akiyama et al., 1996;
Bernardoni et al., 1998; Campbell et al., 1994; Hosoya et al.,
1995; Jones et al., 1995; Klambt, 1993; Klambt and
Goodman, 1991; Schreiber et al., 1997; Vincent et al., 1996;
Xiong et al., 1994). We examined dri expression in embryos
mutant for genes required for glial formation and
differentiation. As expected, dri expression in all of the dorsal
glia (but not in the dri-expressing lateral neural cells) depends
on gcm (Fig. 7B). Moreover, with the probable exception of
the A/B SPG, the normal levels of dri glial expression
requires repo (Fig. 7C), as repo mutant embryos show a
significant reduction in the levels of dri expression and in the
numbers of LG that contain DRI. However, dri expression in
all dorsal glia does not depend on pnt (Fig. 7D). Analysis of
the dri promoter region did not reveal any consensus binding
sites for GCM (A/GCCCGCAT) or REPO (NNATTA, data
not shown), suggesting that dri might be not a direct
transcriptional target of these genes. The finding that dri
expression in all glia is not affected in embryos mutant for
faint little ball (flb), a null allele of the Drosophila EGFR
gene (Fig. 7E,F), is in line with previous observations that
only the midline glia require EGFR signalling.
In a complementary set of experiments, the expression of
glial differentiation markers in a dri mutant background was
examined. In dri loss-of-function mutants, repo, pnt and cut
continue to be expressed in the appropriate glia (Fig. 5; data
not shown). However, we observed a reduction in the number
of pros- and loco-positive glial cells (Fig. 8). One pros-
positive glial cell was found to be consistently missing in dri
mutant embryos (depicted with arrows in Fig. 8A-D), while
there was frequent, if irregular, reduction or loss of pros
expression in three or four other LG (data not shown).
Similarly, loco expression was reduced or lost in some LG,
although this phenotype also exhibited variability in different
segments (Fig. 8E,F). We scored the number of loco-positive
cells in two neuromeres of abdominal segments in ten stage
15 embryos. The average number of dorsal glia per
hemineuromere in dri1/CyOwglacZ heterozygotes was 9.8
(392 totally), not significantly different from wild-type
numbers (Campbell et al., 1994; Halter et al., 1995; Klaes et
al., 1994; Klambt, 1993; Klambt and Goodman, 1991; Xiong
et al., 1994). By contrast, there was an average of 4.8 (193
scored) loco-positive cells per hemineuromere in dri1
homozygotes, confirming the significance of the apparent loss
of loco-expressing cells.
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Fig. 5. The longitudinal glial cells expressing repo and cut are
misplaced in dri mutants. Dorsal view of dissected ventral nerve cord
preparations of dri/CyO wg b gal (A,C,E) and dri1/dri2 homozygous
(B,D,F) stage 16 embryos, immunochemically stained with anti-CT
(A-B) or anti-REPO (C-F) antibodies and AP-conjugated (for REPO
or CT in A-F) and HRP-conjugated (for b -gal in CyO wgb -gal, A, C)
secondary antibody. Anterior is towards the left. (A,C,E) dri
heterozygotes exhibit the proper positions of two rows of glial cells
either side of the midline. (B,D,F) Loss of DRI results in the
misplacement of nuclei marked with CT (compare heterozygotes in
A with dri homozygotes in B) or REPO (compare C with D). Higher
magnification (E,F) more clearly shows that repo-positive nuclei of
the longitudinal glial cells in dri homozygotes do not occupy a flat
layer underlying the longitudinal connectives (F; arrowhead , nucleus
in focus; arrows, mispositioned nuclei out of the focal plane) as in
the wild type (E). 
Fig. 6. Loss of DRI results in downregulation of Neuroglian in
subsets of longitudinal glial cells. Whole-mount immunochemical
staining of wild-type (A-C) and dri1/dri2 (D-F) embryos. Dorsal glial
cells are labelled with Pb -gal (driven by a gcm enhancer trap, green)
and mAb 1B7 against NRG CAM (red). In all panels anterior is
upwards. LG are slightly misplaced in some hemisegments. Some of
those cells do not express Neuroglian and show a rounded cell shape
(arrows in D,F indicate cells shown at higher magnification in inset),
although the penetrance is low, the phenotype being detected on
average in three hemisegments from T1 to A8 in an embryo.
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DISCUSSION
To understand the mechanisms that control formation of the
central nervous system, it is important to identify the genetic
and molecular components involved. We provide evidence that
the transcriptional regulatory gene, dri, is one such component,
required for normal embryonic nervous system development.
The primary evidence for this comes from the axon bundling
and tracking defects observed in dri mutant embryos. The
axon phenotype includes incorrectly bundled and routed
connectives, and axons that sometimes join the wrong bundle
or cross from one tract to another. However, the axon defects
do not reflect a role for dri in neurons. dri is not expressed in
the neurons that give rise to the longitudinal axon bundles, nor
do these neurons exhibit a mutant phenotype in dri mutant
embryos. Rather, dri was found to be expressed in a subset of
glial cells, the longitudinal glia, A and B subperineural glia and
the medialmost cell body glia, where it is required for normal
differentiation and, as a consequence, normal axon fascicle
formation. 
Although dri is expressed early in glial development, two
lines of evidence allow us to conclude that dri does not play a
role in the neural/glial cell fate decision. First, ectopic
expression studies showed that DRI cannot induce a glial cell
fate in non-glial cells, nor was it involved in repression of the
neural fate during glial cell formation. Second, loss of dri
function was found not to impair the initiation of gliogenesis.
The first axon tracts were established correctly, indicating that
the dri mutation does not cause any dramatic glial cell fate
changes. In addition, dri mutant longitudinal glia were still able
to undergo their initial migration to the correct position relative
to the midline and to navigate the growth cones of pioneer
axons. This process depends on the ability of the Robo
receptor, on the glial cell, to recognize the repulsive Slit signal
emanating from the midline (Halter et al., 1995; Jacobs et al.,
1989; Kinrade et al., 2001; Schmidt et al., 1997). Thus, we
conclude that Robo function is not affected in dri mutants. 
After the initial migration and pioneer axon navigation,
however, the behaviour of dri-expressing glial cells becomes
Fig. 7. dri expression in the longitudinal glial cells of the Drosophila
embryonic CNS depends on GCM and REPO. Dorsal view of
dissected embryonic ventral nerve cords immunochemically stained
with anti-DRI and detected with AP-conjugated secondary antibody.
Anterior is towards the left. (A) The distribution of dri-expressing
cells in wild-type embryos. (B) dri expression is completely
abolished in all glial (arrow) but not neural (arrowhead) cells in the
gcmP1 mutants. (C) dri expression is lost from most longitudinal
glial cells but not from the neurone (arrowhead) nor, perhaps, from
A/B SPG (thin arrows) in a repo3 mutant embryo. (D) Expression of
dri in the dorsal glia (arrow) seems to be unaffected in a stage 15
embryo mutant for pnt D 88. (E,F) Expression of dri in the dorsal glia
is also unaffected in stage 15 embryos mutant for flb. (E) One focal
plane, showing MM CBG, long arrow with asterisk. (F) A different
focal plane showing the LG (short arrow) and the dri-positive neural
cells (arrowhead).
Fig. 8. The number of cells expressing loco and pros is reduced in
dri mutants. Dorsal view of dissected ventral nerve cord preparations
of dri/CyO wg b gal (A,C,E) and dri1/dri2 (B,D,F) stage 16 embryos,
immunochemically stained with anti-PROS and anti-b -galactosidase
(A-D), anti-b -galactosidase and anti-DRI antibodies (E,F) and
detected with AP-conjugated (for PROS and rC56 b -gal; A-F) and, in
some cases, HRP-conjugated (for b -gal: A,C; and DRI in E)
secondary antibody. Anterior is towards the left. (A) In dri/CyO
embryos there are five pros-positive cells in the focal plane shown
here. (B) In dri mutant embryos, pros expression is absent in one cell
per hemineuromere, depicted by an arrow. (C,D) Higher
magnifications of A,B, respectively, showing that the four remaining
pros-positive cells are not positioned in a flat sheet as they are in wild
type. (E,F) rC56-directed b -galactosidase expression is reduced or
absent in the longitudinal glia of dri mutant embryos (arrows in F).
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aberrant. The normal final positions of these cells are never
adopted and the cells exhibit cell shape defects. The mild
misplacement of LG in dri mutants is probably caused by
defects in glia-glia and axon-glia contacts, resulting at least in
part from downregulation of the glial cell surface marker
Neuroglian. These defects may interfere with correct migration
of glia along the axon bundles which, in turn, causes the axon
tract defects. 
What is the molecular basis of the mutant phenotype found
in dri mutants? DRI is a transcription factor, so the link
between loss of dri function and the failure to differentiate
properly is likely to be indirect, mediated through
misregulation of dri targets required for normal longitudinal
glial development. The most informative data came from our
analysis of the position of dri in the glial transcriptional
regulatory cascade. In general terms, dri activity was found to
be downstream of gcm and repo, and independent of pnt and
cut. It was also found to be upstream of two genes, loco and
pros, which are essential for normal development of some glial
cells. In this developmental context dri acts as an activator of
downstream targets. A consensus DRI binding-sequence has
been defined (Gregory et al., 1996), but neither the loco nor
pros promoter regions contain such sequences. This raises the
possibility that loco and pros might be indirect targets of
DRI activity in the hierarchy of glial cell differentiation.
Confirmation of this will require further analysis of loco and
pros transcriptional regulation and perhaps the discovery of
additional transcriptional regulatory factors involved in glial
development.
The requirement for DRI in the activation of loco is
unexpected. loco has been found to be a transcriptional target
of PNT but not of REPO (Granderath et al., 2000; Granderath
et al., 1999b), while we found that dri expression depends on
REPO and not on PNT. It is possible that expression of loco is
co-dependent on PNT and DRI in some cells and that the
reduced level of dri expression observed in repo mutants is
enough to permit loco expression. 
The genetic analysis presented here strengthens the
hypothesis that there are different genetic controls for different
subsets of dorsal glia. For example, dri expression in all glial
cells requires GCM activation, but only some of them requires
REPO. The REPO-independent dri-positive cells, two per
hemineuromere, appeared to correspond to the A and B
subperineural glia (A/B SPG). These derive from
neuroglioblast NB1.1 (Halter et al., 1995; Klambt and
Goodman, 1991; Udolph et al., 1993), suggesting that REPO
is required only for the expression of dri in cells derived from
the lateral glioblasts. Unlike dri, pnt and its downstream target
loco are not expressed in the MM CBG, which do not have a
lateral glioblast origin. This suggests that there are different
pathways of pnt and dri induction downstream of gcm.
At least some of these hierarchical transcriptional
interactions may explain the phenotypes observed. The axon
and mild positional defects of glia in dri mutants resemble
phenotypes of other known late gliogenesis factors, such as
those observed in pnt, repo, loco or pros embryos. It is known
that early distribution of the glycoprotein Neuroglian is
perturbed in pros mutant embryos (Jacobs, 1993). loco encodes
a regulator of G-protein signalling (RGS) that has been shown
to bind to a G a i-subunit (Granderath et al., 1999b) and could
regulate a G-protein signalling pathway involved in LG
migratory behaviour. In addition, expression of Heartless, the
Drosophila FGF receptor, in LG, and similarities between the
loco and heartless mutant phenotypes (Granderath et al.,
1999b; Shishido et al., 1997) leaves open the possibility that
FGF could trigger final migration of glia along the longitudinal
connectives. This hypothesis is strengthen by the recent finding
that subcellular redistribution of Neuroglian from the plasma
membrane to cytoplasm, which normally happens during final
glial migration to enwrap axon bundles, is disrupted in
heartless mutants (Takizawa and Hotta, 2001). Alternatively, it
remains possible that additional targets of dri mediate the role
of this gene in longitudinal glial differentiation.
Our studies add dri to the list of genes, including pnt, repo,
loco and pros, that exhibit phenotypes that are much milder
than those of the gcm, glide2 and Drop/Ltt genes at the head
of the dorsal glia hierarchy (Buescher and Chia, 1997;
Campbell et al., 1994; Giesen et al., 1997; Granderath et al.,
1999b; Halter et al., 1995; Kammerer and Giangrande, 2001;
Klaes et al., 1994; Klambt, 1993; Klambt and Goodman, 1991;
Xiong et al., 1994). It appears that diversification of these
downstream regulators produces different types of glial cells.
Nonetheless, each plays an essential role in driving the required
behaviour of glial cells during CNS development. In the case
of the DRI transcription factor, this role includes fine tuning
the cell shape and migration characteristics of longitudinal glia
that enable them to establish a normal axon scaffold.
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